Brief #12447Updated 18 NOV 2025MENLO PARKSOFTWARE COMPANIESGRANT
Employbl DossierCeleris Therapeutics
Harnessing deep learning and lab automation to accelerate drug discovery in targeted protein degradation.
- Founded
- 2021
- Headcount
- 25
- Open roles
- 0
- Last raised
- Grant · $3M
Section II — RestrictedMembers only
- Engineering interview process at Celeris Therapeutics
- Tech stack & infrastructure choices
- Culture & day-to-day work style
- Why join now vs. 6 months from now
- Hiring focus & open headcount by team
- Comp philosophy and band context
7-day free trial · $25/mo · cancel anytime
